Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2355

1.

Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion.

Tawara K, Scott H, Emathinger J, Ide A, Fox R, Greiner D, LaJoie D, Hedeen D, Nandakumar M, Oler AJ, Holzer R, Jorcyk C.

Transl Oncol. 2018 Nov 12;12(2):245-255. doi: 10.1016/j.tranon.2018.10.004. [Epub ahead of print]

2.

C-H Arylation in the Formation of a Complex Pyrrolopyridine, the Commercial Synthesis of the Potent JAK2 Inhibitor, BMS-911543.

Fox RJ, Cuniere NL, Bakrania L, Wei C, Strotman NA, Hay M, Fanfair D, Regens C, Beutner GL, Lawler M, Lobben P, Soumeillant MC, Cohen B, Zhu K, Skliar D, Rosner T, Markwalter CE, Hsiao Y, Tran K, Eastgate MD.

J Org Chem. 2018 Nov 12. doi: 10.1021/acs.joc.8b02383. [Epub ahead of print]

PMID:
30388009
3.

Under expression of the Sonic Hedgehog receptor, Patched1 (PTCH1), is associated with an increased risk of local recurrence in squamous cell carcinoma of the vulva arising on a background of Lichen Sclerosus.

Yap J, Fox R, Narsia N, Pinheiro-Maia S, Pounds R, Woodman C, Luesley D, Ganesan R, Kehoe S, Dawson C.

PLoS One. 2018 Oct 31;13(10):e0206553. doi: 10.1371/journal.pone.0206553. eCollection 2018.

4.

Joint longitudinal and time-to-event models for multilevel hierarchical data.

Brilleman SL, Crowther MJ, Moreno-Betancur M, Buros Novik J, Dunyak J, Al-Huniti N, Fox R, Hammerbacher J, Wolfe R.

Stat Methods Med Res. 2018 Oct 31:962280218808821. doi: 10.1177/0962280218808821. [Epub ahead of print]

PMID:
30378472
5.

The 5-HT2A Receptor (5-HT2AR) Regulates Impulsive Action and Cocaine Cue Reactivity in Male Sprague-Dawley Rats.

Sholler DJ, Stutz SJ, Fox RG, Boone EL, Wang Q, Rice KC, Moeller FG, Anastasio NC, Cunningham KA.

J Pharmacol Exp Ther. 2018 Oct 29. pii: jpet.118.251199. doi: 10.1124/jpet.118.251199. [Epub ahead of print]

6.

A new NBIA patient from Turkey with homozygous C19ORF12 mutation.

Kasapkara ÇS, Tümer L, Gregory A, Ezgü F, İnci A, Derinkuyu BE, Fox R, Rogers C, Hayflick S.

Acta Neurol Belg. 2018 Oct 8. doi: 10.1007/s13760-018-1026-5. [Epub ahead of print] No abstract available.

PMID:
30298423
7.

Use of eHealth and mHealth technology by persons with multiple sclerosis.

Marrie RA, Leung S, Tyry T, Cutter GR, Fox R, Salter A.

Mult Scler Relat Disord. 2018 Oct 2;27:13-19. doi: 10.1016/j.msard.2018.09.036. [Epub ahead of print]

PMID:
30296732
8.

Quality not quantity: loneliness subtypes, psychological trauma, and mental health in the US adult population.

Hyland P, Shevlin M, Cloitre M, Karatzias T, Vallières F, McGinty G, Fox R, Power JM.

Soc Psychiatry Psychiatr Epidemiol. 2018 Oct 6. doi: 10.1007/s00127-018-1597-8. [Epub ahead of print]

PMID:
30293176
9.

Psychosocial Factors Associated with Healthy and Unhealthy Interpregnancy Intervals.

Young R, Lane WG, Stephens SB, Mayden BW, Fox RE.

Health Equity. 2018 Mar 1;2(1):22-29. doi: 10.1089/heq.2017.0017. eCollection 2018.

10.

Symptomatic Vertebral Hemangioma of the Posterior Elements Sharing Blood Supply with a Radiculomedullary Artery.

Persad AR, Fox RJ, Rempel JL.

Int J Spine Surg. 2018 Aug 31;12(4):415-418. doi: 10.14444/5049. eCollection 2018 Aug.

11.

Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis.

Baldassari LE, Fox RJ.

Drugs. 2018 Oct;78(15):1549-1566. doi: 10.1007/s40265-018-0984-5. Review.

PMID:
30255442
12.

A locus on barley chromosome 5H affects adult plant resistance to powdery mildew.

Gupta S, Vassos E, Sznajder B, Fox R, Khoo KHP, Loughman R, Chalmers KJ, Mather DE.

Mol Breed. 2018;38(8):103. doi: 10.1007/s11032-018-0858-2. Epub 2018 Jul 28.

13.

Advances in the Treatment of Metastatic Renal Cell Carcinoma.

Bergerot P, Burns K, Prajapati D, Fox R, Salgia M, Pal SK.

Cancer Treat Res. 2018;175:127-137. doi: 10.1007/978-3-319-93339-9_6.

PMID:
30168120
14.

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.

Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A; NN102/SPRINT-MS Trial Investigators.

N Engl J Med. 2018 Aug 30;379(9):846-855. doi: 10.1056/NEJMoa1803583.

PMID:
30157388
15.

Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.

Trapp BD, Vignos M, Dudman J, Chang A, Fisher E, Staugaitis SM, Battapady H, Mork S, Ontaneda D, Jones SE, Fox RJ, Chen J, Nakamura K, Rudick RA.

Lancet Neurol. 2018 Oct;17(10):870-884. doi: 10.1016/S1474-4422(18)30245-X. Epub 2018 Aug 22.

PMID:
30143361
16.

Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers.

Vollmer B, Ontaneda D, Bandyopadhyay A, Cohn S, Nair K, Sillau S, Bermel RA, Corboy JR, Fox RJ, Vollmer T, Cohen JA, Alvarez E, Hersh CM.

Neurol Clin Pract. 2018 Aug;8(4):292-301. doi: 10.1212/CPJ.0000000000000487.

17.

Unmet supportive care needs in Hispanic/Latino cancer survivors: prevalence and associations with patient-provider communication, satisfaction with cancer care, and symptom burden.

Moreno PI, Ramirez AG, San Miguel-Majors SL, Castillo L, Fox RS, Gallion KJ, Munoz E, Estabrook R, Perez A, Lad T, Hollowell C, Penedo FJ.

Support Care Cancer. 2018 Aug 22. doi: 10.1007/s00520-018-4426-4. [Epub ahead of print]

PMID:
30136022
18.
19.

Progressive multifocal leukoencephalopathy with extended natalizumab dosing.

Baldassari LE, Jones SE, Clifford DB, Fox RJ.

Neurol Clin Pract. 2018 Jun;8(3):e12-e14. doi: 10.1212/CPJ.0000000000000457. No abstract available.

PMID:
30105172
20.

Good parenting may not increase reproductive success under environmental extremes.

Fox RJ, Head ML, Barber I.

J Evol Biol. 2018 Nov;31(11):1638-1646. doi: 10.1111/jeb.13358. Epub 2018 Aug 19.

PMID:
30063102
21.

Scan-rescan repeatability and cross-scanner comparability of DTI metrics in healthy subjects in the SPRINT-MS multicenter trial.

Zhou X, Sakaie KE, Debbins JP, Narayanan S, Fox RJ, Lowe MJ.

Magn Reson Imaging. 2018 Nov;53:105-111. doi: 10.1016/j.mri.2018.07.011. Epub 2018 Jul 23.

PMID:
30048675
22.

Data standards for model-informed drug development: an ISoP initiative.

Radivojevic A, Corrigan B, Downie N, Fox R, Fiedler-Kelly J, Liu H, Melhem M, Radke D, Schaefer P, Su J, Swat MJ, Teuscher NS, Thanneer N, Zong A, Wilkins JJ.

J Pharmacokinet Pharmacodyn. 2018 Oct;45(5):659-661. doi: 10.1007/s10928-018-9595-8. Epub 2018 Jul 25. No abstract available.

PMID:
30046963
23.

Prospects of siponimod in secondary progressive multiple sclerosis.

McGinley M, Fox RJ.

Ther Adv Neurol Disord. 2018 Jul 17;11:1756286418788013. doi: 10.1177/1756286418788013. eCollection 2018. No abstract available.

24.

Reverse Hydroxamate Inhibitors of Bone Morphogenetic Protein 1.

Kallander LS, Washburn D, Hilfiker MA, Eidam HS, Lawhorn BG, Prendergast J, Fox R, Dowdell S, Manns S, Hoang T, Zhao S, Ye G, Hammond M, Holt DA, Roethke T, Hong X, Reid RA, Gampe R, Zhang H, Diaz E, Rendina AR, Quinn AM, Willette B.

ACS Med Chem Lett. 2018 Jul 2;9(7):736-740. doi: 10.1021/acsmedchemlett.8b00173. eCollection 2018 Jul 12.

PMID:
30034610
25.

Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink.

Wilding J, Godec T, Khunti K, Pocock S, Fox R, Smeeth L, Clauson P, Fenici P, Hammar N, Medina J.

BMC Med. 2018 Jul 16;16(1):116. doi: 10.1186/s12916-018-1085-8.

26.

Technical Note: Retrospective reduction in systematic differences across scanner changes by accounting for noise floor effects in diffusion tensor imaging.

Sakaie K, Zhou X, Lin J, Debbins J, Lowe M, Fox RJ.

Med Phys. 2018 Jul 11. doi: 10.1002/mp.13088. [Epub ahead of print]

PMID:
29998491
27.

Notch signaling promotes a HIF2α-driven hypoxic response in multiple tumor cell types.

Mutvei AP, Landor SK, Fox R, Braune EB, Tsoi YL, Phoon YP, Sahlgren C, Hartman J, Bergh J, Jin S, Lendahl U.

Oncogene. 2018 Jul 11. doi: 10.1038/s41388-018-0400-3. [Epub ahead of print]

PMID:
29993038
28.

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder.

Dimet AL, Cisneros IE, Fox RG, Stutz SJ, Anastasio NC, Cunningham KA, Dineley KT.

J Vis Exp. 2018 Jun 18;(136). doi: 10.3791/55864.

PMID:
29985329
29.

Non-invasive spinal vibration testing using ultrafast ultrasound imaging: A new way to measure spine function.

Kaddoura T, Au A, Kawchuk G, Uwiera R, Fox R, Zemp R.

Sci Rep. 2018 Jun 25;8(1):9611. doi: 10.1038/s41598-018-27816-0.

30.

Image Challenge: An Engaging New Feature in Veterinary Pathology.

Craig L, Fox R, Langohr I.

Vet Pathol. 2018 Jul;55(4):485. doi: 10.1177/0300985818771148. No abstract available.

PMID:
29890928
31.

Patient-Reported Disease-Modifying Therapy Adherence in the Clinic: A Reliable Metric?

Conway DS, Cecilia Vieira M, Thompson NR, Parker KN, Meng X, Fox RJ.

Mult Scler J Exp Transl Clin. 2018 May 23;4(2):2055217318777894. doi: 10.1177/2055217318777894. eCollection 2018 Apr-Jun.

32.

Outcomes in Thoracolumbar Burst Fractures With a Thoracolumbar Injury Classification Score (TLICS) of 4 Treated With Surgery Versus Initial Conservative Management.

Nataraj A, Jack AS, Ihsanullah I, Nomani S, Kortbeek F, Fox R.

Clin Spine Surg. 2018 Jul;31(6):E317-E321. doi: 10.1097/BSD.0000000000000656.

PMID:
29847416
33.

Adolescent Summaries of Narrative and Expository Discourse: Differences and Predictors.

Lundine JP, Harnish SM, McCauley RJ, Blackett DS, Zezinka A, Chen W, Fox RA.

Lang Speech Hear Serv Sch. 2018 Jul 5;49(3):551-568. doi: 10.1044/2018_LSHSS-17-0105.

PMID:
29801092
34.

Comprehensive genetic testing for female and male infertility using next-generation sequencing.

Patel B, Parets S, Akana M, Kellogg G, Jansen M, Chang C, Cai Y, Fox R, Niknazar M, Shraga R, Hunter C, Pollock A, Wisotzkey R, Jaremko M, Bisignano A, Puig O.

J Assist Reprod Genet. 2018 Aug;35(8):1489-1496. doi: 10.1007/s10815-018-1204-7. Epub 2018 May 19.

35.

The incidence of pulmonary hypertension is higher in systemic lupus and Sjögren's patients than in scleroderma patients in China.

Fox RI.

Lupus. 2018 Jun;27(7):1051-1052. doi: 10.1177/0961203318772019. No abstract available.

PMID:
29732959
36.

Can Circadian Dysregulation Exacerbate Migraines?

Ong JC, Taylor HL, Park M, Burgess HJ, Fox RS, Snyder S, Rains JC, Espie CA, Wyatt JK.

Headache. 2018 Jul;58(7):1040-1051. doi: 10.1111/head.13310. Epub 2018 May 4.

PMID:
29727473
37.

Temperature influences habitat preference of coral reef fishes: Will generalists become more specialised in a warming ocean?

Matis PA, Donelson JM, Bush S, Fox RJ, Booth DJ.

Glob Chang Biol. 2018 Jul;24(7):3158-3169. doi: 10.1111/gcb.14166. Epub 2018 May 20.

PMID:
29658157
38.

Regional Variation in Fundamental Frequency of American English Vowels.

Jacewicz E, Fox RA.

Phonetica. 2018;75(4):273-309. doi: 10.1159/000484610. Epub 2018 Apr 11.

PMID:
29649804
39.

Haematopoietic stem cells in cirrhosis - Authors' reply.

Newsome PN, Fox R, Forbes SJ.

Lancet Gastroenterol Hepatol. 2018 May;3(5):298-299. doi: 10.1016/S2468-1253(18)30035-9. Epub 2018 Apr 6. No abstract available.

PMID:
29644971
40.

Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis.

Planchon SM, Lingas KT, Reese Koç J, Hooper BM, Maitra B, Fox RM, Imrey PB, Drake KM, Aldred MA, Lazarus HM, Cohen JA.

Mult Scler J Exp Transl Clin. 2018 Mar 26;4(1):2055217318765288. doi: 10.1177/2055217318765288. eCollection 2018 Jan-Mar.

41.

Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance.

Muraro PA, Scolding NJ, Fox RJ.

Neurology. 2018 May 1;90(18):819-820. doi: 10.1212/WNL.0000000000005409. Epub 2018 Mar 30. No abstract available.

PMID:
29602911
42.

Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis.

Wang H, Swann R, Thomas E, Innes HA, Valerio H, Hayes PC, Allen S, Barclay ST, Wilks D, Fox R, Bhattacharyya D, Kennedy N, Morris J, Fraser A, Stanley AJ, Gunson R, Mclntyre PG, Hunt A, Hutchinson SJ, Mills PR, Dillon JF.

J Viral Hepat. 2018 Aug;25(8):930-938. doi: 10.1111/jvh.12897. Epub 2018 Apr 15.

PMID:
29577515
43.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.

Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T, Wolf C, Wallström E, Dahlke F; EXPAND Clinical Investigators.

Lancet. 2018 Mar 31;391(10127):1263-1273. doi: 10.1016/S0140-6736(18)30475-6. Epub 2018 Mar 23.

PMID:
29576505
44.

Pragmatic trial of a multidisciplinary lung cancer care model in a community healthcare setting: study design, implementation evaluation, and baseline clinical results.

Smeltzer MP, Rugless FE, Jackson BM, Berryman CL, Faris NR, Ray MA, Meadows M, Patel AA, Roark KS, Kedia SK, DeBon MM, Crossley FJ, Oliver G, McHugh LM, Hastings W, Osborne O, Osborne J, Ill T, Ill M, Jones W, Lee HK, Signore RS, Fox RC, Li J, Robbins ET, Ward KD, Klesges LM, Osarogiagbon RU.

Transl Lung Cancer Res. 2018 Feb;7(1):88-102. doi: 10.21037/tlcr.2018.01.02.

45.

Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36 (2014) 1958-1971].

Kita M, Fox RJ, Gold R, Giovannoni G, Phillips JT, Sarda SP, Kong J, Viglietta V, Sheikh SI, Okwuokenye M, Kappos L.

Clin Ther. 2018 May;40(5):812. doi: 10.1016/j.clinthera.2018.02.005. Epub 2018 Mar 7. No abstract available.

PMID:
29523369
46.

Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study.

Merz EL, Kwakkenbos L, Carrier ME, Gholizadeh S, Mills SD, Fox RS, Jewett LR, Williamson H, Harcourt D, Assassi S, Furst DE, Gottesman K, Mayes MD, Moss TP, Thombs BD, Malcarne VL; SPIN Investigators.

BMJ Open. 2018 Mar 6;8(3):e018641. doi: 10.1136/bmjopen-2017-018641.

47.

A survey of dietary characteristics in a large population of people with multiple sclerosis.

Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox RJ, Marrie RA.

Mult Scler Relat Disord. 2018 May;22:12-18. doi: 10.1016/j.msard.2018.02.019. Epub 2018 Feb 27.

PMID:
29510324
48.

Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial.

Foster GR, Agarwal K, Cramp ME, Moreea S, Barclay S, Collier J, Brown AS, Ryder SD, Ustianowski A, Forton DM, Fox R, Gordon F, Rosenberg WM, Mutimer DJ, Du J, Gilbert CL, Asante-Appiah E, Wahl J, Robertson MN, Barr E, Haber B.

Hepatology. 2018 Jun;67(6):2113-2126. doi: 10.1002/hep.29852. Epub 2018 Apr 19.

PMID:
29473975
49.

Strategy To Prepare 3-Bromo- and 3-Chloropyrazoles.

Fox RJ, Schmidt MA, Eastgate MD.

J Org Chem. 2018 Mar 2;83(5):2830-2839. doi: 10.1021/acs.joc.7b03282. Epub 2018 Feb 19.

PMID:
29429343
50.

Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.

Fox RS, Kwakkenbos L, Carrier ME, Mills SD, Gholizadeh S, Jewett LR, Roesch SC, Merz EL, Assassi S, Furst DE, Gottesman K, Mayes MD, Thombs BD, Malcarne VL; and the SPIN Investigators.

Arthritis Care Res (Hoboken). 2018 Nov;70(11):1646-1652. doi: 10.1002/acr.23532.

PMID:
29409146

Supplemental Content

Support Center